Cardiovascular Diseases:
Heart Attack and Heart Failure

Chest pain and shortness of breath are leading reasons for visits to U.S. emergency departments. Information from the National Hospital Ambulatory Medical Care Survey suggests that in 2003 there were more than 5 million emergency department visits made by adults suffering from chest pain and more than 4 million visits related to breathing difficulty. Additionally, the American Heart Association reports that in 2002, nearly five million individuals in the United States suffered from heart failure, with 550,000 new cases diagnosed. For these patients, time is a significant factor. Early detection of heart failure or heart attack significantly improves a patient's chances for living and minimizes the chances for permanent damage to tissue and organs.

Click on the product names for more information relating to:

Triage^® Cardiac Panel

A rapid, objective aid in the diagnosis of heart attack, the Triage Cardiac Panel measures three key cardiac markers: myoglobin, CK-MB, and troponin I. The system is easy-to-use, with results delivered in approximately 15 minutes.

Triage BNP Test

Used in more than 3,000 hospitals and physician offices, the Triage BNP Test aids in the diagnosis and severity assessment of heart failure. The product is also cleared for use in the risk stratification of patients with acute coronary syndromes.

Triage Cardio ProfilER

With the Triage Cardio ProfilER, physicians can easily obtain the measurements of four cardiovascular markers in approximately 15 minutes, without sacrificing accuracy. This rapid turnaround time enables physicians to more efficiently diagnose chest pain patients, provides a better understanding of the event, and reduces the time-to-diagnose. Troponin I, CK-MB, myoglobin, and BNP each provide unique clinical information, and the panel approach maximizes the strengths of each marker.

Triage Profiler Shortness of Breath Panel

With the Triage Profiler Shortness of Breath Panel, physicians can easily obtain the measurements of five markers in approximately 15 minutes, without sacrificing accuracy. This rapid turnaround time enables physicians to more efficiently diagnose patients who present with shortness of breath, provides a better understanding of the event, and reduces the time-to-diagnose. Troponin I, CK-MB, myoglobin, BNP and D-dimer each provide unique clinical information, and the panel approach maximizes the strengths of each marker.